Skip to main content
SLU:s publikationsdatabas (SLUpub)

Sammanfattning

BackgroundThe microbial metabolite Trimethylamine-N-oxide (TMAO) has been linked to adverse cardiovascular outcome and mortality in the general population.ObjectiveTo assess the contribution of TMAO to inflammation and mortality in chronic kidney disease (CKD) patients ranging from mild-moderate to end-stage disease and 1) associations with glomerular filtration rate (GFR) 2) effect of dialysis and renal transplantation (Rtx) 3) association with inflammatory biomarkers and 4) its predictive value for all-cause mortality.MethodsLevels of metabolites were quantified by a novel liquid chromatography/tandem mass spectrometry-based method in fasting plasma samples from 80 controls and 179 CKD 3-5 patients. Comorbidities, nutritional status, biomarkers of inflammation and GFR were assessed.ResultsGFR was the dominant variable affecting TMAO (beta = -0.41; p

Publicerad i

PLoS ONE
2016, volym: 11, nummer: 1, artikelnummer: e0141738
Utgivare: PUBLIC LIBRARY SCIENCE

SLU författare

Globala målen (SDG)

SDG3 God hälsa och välbefinnande

UKÄ forskningsämne

Klinisk medicin

Publikationens identifierare

  • DOI: https://doi.org/10.1371/journal.pone.0141738

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/83280